James C. Clemmer is the President and CEO of AngioDynamics Inc., a leading provider of medical devices used in minimally invasive procedures. With a strong background in the medical device industry, Clemmer has been instrumental in driving the company's growth and innovation. He joined AngioDynamics in 2016 as President and Chief Operating Officer before being promoted to CEO in 2017 and President and CEO in 2020. Prior to his tenure at AngioDynamics, Clemmer held various leadership positions at prominent medical device companies. He served as the President of the Americas at Covidien's Vascular Therapies division, where he played a key role in expanding the company's market presence. Clemmer also held executive positions at Boston Scientific Corporation, including Vice President and General Manager of the Endosurgery Division. His extensive experience in the industry has equipped him with the knowledge and skills necessary to lead AngioDynamics in its mission to improve patient outcomes through innovative medical technologies. As President and CEO of AngioDynamics, Clemmer is responsible for overseeing the company's strategic direction and operational performance. Under his leadership, AngioDynamics has focused on developing and commercializing cutting-edge products in the fields of vascular access, peripheral vascular disease, and oncology. Clemmer's vision for the company includes expanding its global reach and strengthening its position as a leader in the medical device industry. His commitment to fostering a culture of innovation and excellence has been a driving force behind AngioDynamics' success in delivering life-changing solutions to patients worldwide.